Skip to content
10-Q

Quarterly Report

Auspex Pharmaceuticals, Inc.

0001564590-14-003328

← back to feed
Filed
Aug 7, 2014 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2014 · Aug 1, 2014 27.34M sh
Capex Q2 2014 · Jun 30, 2014 $128K
Capex Q2 2014 · Jun 30, 2013 $5K
Long Term Debt Q2 2014 · Jun 30, 2014 $14.51M
Long Term Debt Q2 2014 · Dec 31, 2013 $14.42M
Cash And Equivalents Q2 2014 · Jun 30, 2014 $14.64M
Cash And Equivalents Q2 2014 · Dec 31, 2013 $36.65M
Cash And Equivalents Q2 2014 · Jun 30, 2013 $1.23M
Cash And Equivalents Q2 2014 · Dec 31, 2012 $4.28M
Stockholders Equity Q2 2014 · Jun 30, 2014 $92.37M
Stockholders Equity Q2 2014 · Dec 31, 2013 −$64.94M
Current Liabilities Q2 2014 · Jun 30, 2014 $6.45M
Current Liabilities Q2 2014 · Dec 31, 2013 $3.49M
Total Liabilities Q2 2014 · Jun 30, 2014 $21.15M
Total Liabilities Q2 2014 · Dec 31, 2013 $21.96M
Current Assets Q2 2014 · Jun 30, 2014 $112.9M
Current Assets Q2 2014 · Dec 31, 2013 $36.89M
Total Assets Q2 2014 · Jun 30, 2014 $113.52M
Total Assets Q2 2014 · Dec 31, 2013 $38.87M
Sga Expense Q2 2014 · Jun 30, 2014 $2.91M
Sga Expense Q2 2014 · Jun 30, 2014 $5.58M
Sga Expense Q2 2014 · Jun 30, 2013 $385K
Sga Expense Q2 2014 · Jun 30, 2013 $1.28M
Rd Expense Q2 2014 · Jun 30, 2014 $7.13M
Rd Expense Q2 2014 · Jun 30, 2014 $10.56M
Rd Expense Q2 2014 · Jun 30, 2013 $2.43M
Rd Expense Q2 2014 · Jun 30, 2013 $4.16M
Net Income Q2 2014 · Jun 30, 2014 −$10.39M
Net Income Q2 2014 · Jun 30, 2014 −$20.51M
Net Income Q2 2014 · Jun 30, 2013 −$2.89M
Net Income Q2 2014 · Jun 30, 2013 −$5.19M
Operating Income Q2 2014 · Jun 30, 2014 −$10.04M
Operating Income Q2 2014 · Jun 30, 2014 −$16.15M
Operating Income Q2 2014 · Jun 30, 2013 −$2.82M
Operating Income Q2 2014 · Jun 30, 2013 −$5.45M